Meet Our Editorial Board Member

Abdul       Ahad

doi:10.2174/156720181801201203091600

[1] 
AlRabiah, H.; Ahad, A.; Mostafa, G.A.E.; Al-Jenoobi, F.I. Effect of naltrexone hydrochloride on cytochrome P450 1A2, 2C9, 2D6, and 3A4 activity in human liver microsomes. Euro. J. Drug Metabol Pharmacokin.,  2018, 43(6), 707-713.
[2] 
Albassam, A.A.; Ahad, A.; Alsultan, A.; Al-Jenoobi, F.I. Inhibition of cytochrome P450 enzymes by thymoquinone in human liver microsomes. Saudi Pharmaceut J.,  2018, 26(5), 673-677.
[3] 
Thapa, C.; Ahad, A.; Aqil, M.; Imam, S.S.; Sultana, Y. Formulation and optimization of nanostructured lipid carriers to enhance oral bioavailability of telmisartan using Box–Behnken design. J. Drug Deliv. Sci. Technol.,  2018, 44, 431-439.
[4] 
Ahad, A.; Raish, M.; Al-Jenoobi, F.I.; Al-Mohizea, A.M. Sorbitane monostearate and cholesterol based niosomes for oral delivery of telmisartan. Curr. Drug Deliv.,  2018, 15(2), 260-266.

Download Options

Rights & Permissions Print Cite

Current Drug Delivery

Title:Meet Our Editorial Board Member

Volume: 18 Issue: 1

Author(s): Abdul Ahad

Affiliation:

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Ahad Abdul , Meet Our Editorial Board Member, Current Drug Delivery 2021; 18 (1) . https://dx.doi.org/10.2174/156720181801201203091600

DOI https://dx.doi.org/10.2174/156720181801201203091600	Print ISSN 1567-2018
Publisher Name Bentham Science Publisher	Online ISSN 1875-5704

About this journal

Call for Papers in Thematic Issues

Submission closes on : 31 December, 2025

Advancements in Robotic and AI-Based Drug Discovery and Delivery for Neurological Disorders

Neurological disorders, including Alzheimer's disease, Parkinson's disease, epilepsy, and brain tumors, pose significant challenges in drug delivery due to the blood-brain barrier's intricate structure and the complexity of neuronal networks. Traditional drug delivery methods often fall short in reaching therapeutic concentrations within the central nervous system, limiting treatment efficacy and ...read more

Guest Editor(s): Dr. Indranath Chatterjee

Submission closes on : 31 December, 2025

Advances of natural products, bio-actives and novel drug delivery system against emerging viral infections

Due to the increasing prevalence of viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compounds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable ...read more

Guest Editor(s): Dr. Munish Garg

Submission closes on : 31 December, 2025

Electrospun Fibers as Drug Delivery Systems

In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more

Guest Editor(s): Dr. Luis Jesús Villarreal-Gómez

Submission closes on : 31 December, 2025

Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders

Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access to both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more

Guest Editor(s): Dr. Rahul Shukla